These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients. Thompson LO; Skrabal CA; Loebe M; Lafuente JA; Roberts RR; Akgul A; Jones V; Bruckner BA; Thohan V; Noon GP; Youker KA J Surg Res; 2005 Jan; 123(1):25-32. PubMed ID: 15652947 [TBL] [Abstract][Full Text] [Related]
5. Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support. Lok SI; Nous FM; van Kuik J; van der Weide P; Winkens B; Kemperman H; Huisman A; Lahpor JR; de Weger RA; de Jonge N Eur J Cardiothorac Surg; 2015 Sep; 48(3):407-15. PubMed ID: 25609773 [TBL] [Abstract][Full Text] [Related]
6. Association of pre-operative interleukin-6 levels with Interagency Registry for Mechanically Assisted Circulatory Support profiles and intensive care unit stay in left ventricular assist device patients. Caruso R; Verde A; Cabiati M; Milazzo F; Boroni C; Del Ry S; Parolini M; Vittori C; Paino R; Martinelli L; Giannessi D; Frigerio M; Parodi O J Heart Lung Transplant; 2012 Jun; 31(6):625-33. PubMed ID: 22386451 [TBL] [Abstract][Full Text] [Related]
7. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device. Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217 [TBL] [Abstract][Full Text] [Related]
8. B-Type Natriuretic Peptide Levels Predict Ventricular Arrhythmia Post Left Ventricular Assist Device Implantation. Hellman Y; Malik AS; Lin H; Shen C; Wang IW; Wozniak TC; Hashmi ZA; Pickrell J; Jani M; Caccamo MA; Gradus-Pizlo I; Hadi A Artif Organs; 2015 Dec; 39(12):1051-5. PubMed ID: 25864448 [TBL] [Abstract][Full Text] [Related]
9. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508 [TBL] [Abstract][Full Text] [Related]
10. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far? Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547 [TBL] [Abstract][Full Text] [Related]
12. Impact of age on outcomes following continuous-flow left ventricular assist device implantation. Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085 [TBL] [Abstract][Full Text] [Related]
13. Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation. Morgan JA; Brewer RJ; Nemeh HW; Murthy R; Williams CT; Lanfear DE; Tita C; Paone G ASAIO J; 2012; 58(6):574-7. PubMed ID: 23103696 [TBL] [Abstract][Full Text] [Related]